Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 13, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$31.2B
sum of reported positions
Reported positions
756
Changes vs prior quarter
722
184 new · 41 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 233 measured positions in 8 quarters, the typical new or larger position finished −3.6 pts against the S&P 500 and 39% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $20.6B | $31.2B |
| Positions | 613 | 756 |
| Biggest line | — | INVESCO EXCH TRADED FD TR II 8% |
| 2.56M |
| $954M |
| 3.1% |
| 2.38M | $841M | 2.7% |
ISHARES TR | 1.06M | $797M | 2.6% |
| 1.7M | $642M | 2.1% |
| 2.17M | $629M | 2.0% |
| 1.07M | $619M | 2.0% |
| 1.49M | $531M | 1.7% |
| 941K | $530M | 1.7% |
| 946K | $486M | 1.6% |
| 388K | $465M | 1.5% |
| 851K | $407M | 1.3% |
| 320K | $369M | 1.2% |
| 390K | $282M | 0.9% |
ISHARES TR | 3.62M | $272M | 0.9% |
| 627K | $272M | 0.9% |
| 4.4M | $251M | 0.8% |
| 742K | $243M | 0.8% |
| 470K | $236M | 0.8% |
| 2.05M | $233M | 0.7% |
| 3.01M | $224M | 0.7% |
| 748K | $223M | 0.7% |
Boston Scientific (BSX)
703K → 367K shares (−48%)
Core & Main (CNM)
358K → 321K shares (−10%)
Astrazeneca (AZN)
81K shares
CVS Health (CVS)
106K → 147K shares (+39%)
McDonald's (MCD)
41K → 56K shares (+38%)
Waste Management (WM)
58K → 67K shares (+16%)
AppLovin (APP)
109K → 29K shares (−73%)
Coeur Mining (CDE)
642K → 906K shares (+41%)
Vertex Pharmaceuticals (VRTX)
14K → 29K shares (+106%)
Bruker (BRKR)
252K → 237K shares (−6%)
Solstice Advanced Materials (SOLS)
68K → 160K shares (+135%)
ISHARES TR
284K shares
Medpace (MEDP)
21K → 26K shares (+26%)
Thredup (TDUP)
1.81M → 2.03M shares (+12%)
Badger Meter, Inc. (BMI)
41K → 93K shares (+127%)
ELECTRONIC ARTS INC
3,573 → 66K shares (+1759%)
Pfizer (PFE)
225K → 561K shares (+149%)
Parker Hannifin (PH)
4,879 → 14K shares (+178%)
Hecla Mining (HL)
539K → 843K shares (+56%)
Morgan Stanley (MS)
14K → 61K shares (+337%)
Regeneron Pharmaceuticals (REGN)
12K → 20K shares (+74%)
Take-Two Interactive (TTWO)
8,359 → 51K shares (+506%)
Natera (NTRA)
48K → 46K shares (−4%)
Salesforce (CRM)
343K → 79K shares (−77%)
INVESCO EXCH TRADED FD TR II
273K shares
